Abstract Details
|
Fabio Nascimento, MD
(Washington University Medical School)
PRESENTER |
Dr. Nascimento has received publishing royalties from a publication relating to health care. |
| Felippe Borlot, MD (University of Manitoba) | Dr. Borlot has nothing to disclose. |
| Patrick Cossette, MD (CHUM) | No disclosure on file |
| Berge A. Minassian, MD (Univeristy of Texas Southwestern Medical Center) | Dr. Minassian has nothing to disclose. |
| Danielle M. Andrade, MD (University of Toronto) | The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities. |